Sandeep Tak MD(AIIMS Delhi), FACE (@drstak70) 's Twitter Profile
Sandeep Tak MD(AIIMS Delhi), FACE

@drstak70

#Physician _ #Diabetes/Teacher_Prof of Medicine/Student of #Life.

#Medtweet, #Endotweet, #Diabetes

ID: 3024158028

linkhttp://www.drstak.blogspot.com calendar_today17-02-2015 16:15:16

3,3K Tweet

1,1K Followers

517 Following

JAMA (@jama_current) 's Twitter Profile Photo

In patients with knee osteoarthritis and overweight or obesity, metformin, 2000 mg/d, for 6 months had a moderate and statistically significant effect on knee pain reduction compared with placebo. ja.ma/43TzAae

In patients with knee osteoarthritis and overweight or obesity, metformin, 2000 mg/d, for 6 months had a moderate and statistically significant effect on knee pain reduction compared with placebo. 

ja.ma/43TzAae
NEJM (@nejm) 's Twitter Profile Photo

Presented at #ERA25: In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results:

Presented at #ERA25: 

In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results:
M Shafi Kuchay (@drshafikuchay) 's Twitter Profile Photo

First biopsy-based RCT. MASH improvement in 53% of participants with dapagliflozin vs. 30% with placebo group (P=0.006). MASH resolution in 23% vs. 8%. Fibrosis improvement in 45% vs. 20% (P=0.001). SGLT2 inhibits hv huge benefits in fatty liver disease. bmj.com/content/389/bm…

anoop misra (@docanoopmisra) 's Twitter Profile Photo

New Review (Anoop Misra, S. Joshi, A. Mithal) in #Diabetes & Metab Syndr questions rebranding #Malnutrition-Related Diabetes Mellitus (MRDM) as "#Type5 Diabetes." Ā· Declining #undernutrition Ā· Weak #evidence, outdated #criteria Ā· More research needed before reclassification.

Vishal Gulati (I back scientists) (@vishalgulati_) 's Twitter Profile Photo

Most people have heard of DNA but what about PNA? They are a synthetic peptide nucleic acids (PNAs), that bind even more strongly to nucleic acids and are not broken down in the body by enzymes that target DNA or RNA. These qualities make them good drug candidates. Two drugs are

Sandeep Tak MD(AIIMS Delhi), FACE (@drstak70) 's Twitter Profile Photo

Just a reminder that all this spectacle started with Indian's (both patients & doctors) obsession with injection for minor issues which can well be treated with oral treatment and use of inappropriate medications (by doctors, in this case vit B12 for sciatica) which is totally

Sandeep Tak MD(AIIMS Delhi), FACE (@drstak70) 's Twitter Profile Photo

Early statin use immediately after a type 2 #diabetes diagnosis can reduce cardiovascular events by one-third. ahajournals.org/doi/10.1161/JA…

Sandeep Tak MD(AIIMS Delhi), FACE (@drstak70) 's Twitter Profile Photo

#Metformin initiation in women >60 yrs, with type 2 diabetes. increased chances of reaching exceptional longevity, 90 years and beyond, compared with sulfonylurea initiation. academic.oup.com/biomedgerontol…

Sandeep Tak MD(AIIMS Delhi), FACE (@drstak70) 's Twitter Profile Photo

Metformin: An Old Drug with New Tricks—Promising Role in Vascular Aging and Cardioprotection link.springer.com/article/10.100…

anoop misra (@docanoopmisra) 's Twitter Profile Photo

We present guidelines for #MASLD diagnosis and management in #India — developed first globally (before #ADA), fully India-focused, free of industry influence, original, unbiased, and based on our group’s key #research papers.

We present guidelines for #MASLD diagnosis and management in #India — developed first globally (before #ADA), fully India-focused, free of industry influence, original, unbiased, and based on our group’s key #research papers.
Sandeep Tak MD(AIIMS Delhi), FACE (@drstak70) 's Twitter Profile Photo

This breakthrough, led by researchers at the University of Edinburgh and published in Nature Chemistry (2025), demonstrates a novel way to upcycle plastic waste into valuable pharmaceuticals while reducing reliance on fossil fuels. However, commercial application requires further

Ramon Bataller (@rabataller) 's Twitter Profile Photo

Today, NEJM reports that Efruxifermin (an FGF21 agonist) is the first drug to reduce fibrosis in compensated cirrhosis due to NASH. This effect is seen after 96 weeks, so patience is key. Could combining Semaglutide make it even more powerful?

Today, <a href="/NEJM/">NEJM</a> reports that Efruxifermin (an FGF21 agonist) is the first drug to reduce fibrosis in compensated cirrhosis due to NASH. 

This effect is seen after 96 weeks, so patience is key. 

Could combining Semaglutide make it even more powerful?
anoop misra (@docanoopmisra) 's Twitter Profile Photo

Diabetes, Metabolic and Nutrition Clinics of India (2/3). Please read. (3/3) #Metformin and #KidneyProtection, Metformin Protects Kidney Function #Lp(a)-Lowering Agents Development: New Agents Lower Lp(a) #GLP-1 Agonists and #Cancer: GLP-1 Agonists drive.google.com/file/d/1FqRqvC…

Dr Ashish Kumar (@drashish_kumar) 's Twitter Profile Photo

🚨 Excited to share that my review article on MASLD pharmacotherapy is now published in the July 2025 issue of the Journal of the Association of Physicians of India (JAPI)! Here is a short thread 🧵 about it. japi.org/article/japi-7…

Sandeep Tak MD(AIIMS Delhi), FACE (@drstak70) 's Twitter Profile Photo

Chronic venous insufficiency #CVI or #VaricoseVeins, is when leg veins struggle to pump blood back to the heart, causing swelling, aching, or heaviness. Damaged vein valves let blood pool, like a backed-up pipe. Early on, it’s uncomfortable but manageable with lifestyle changes

Chronic venous insufficiency #CVI or #VaricoseVeins, is when leg veins struggle to pump blood back to the heart, causing swelling, aching, or heaviness. Damaged vein valves let blood pool, like a backed-up pipe. Early on, it’s uncomfortable but manageable with lifestyle changes